EVKIF (Evonik Industries AG) ROCE %: 6.30% (As of Mar. 2026)


EVKIF Evonik Industries AG EVKIF
61 GF Score
Price $17.25
GF Value $17.29
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Evonik Industries AG ROCE %?

Evonik Industries AG EVKIF +1.47% 61 ROCE % is 6.30% as of Mar. 2026. GuruFocus rates EVKIF with a GF Score™ of 61/100 and a GF Value™ of $17.29 (Fairly Valued). The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Evonik Industries AG's annualized ROCE % for the quarter that ended in Mar. 2026 was 6.30%.


Evonik Industries AG  (OTCPK:EVKIF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Evonik Industries AG ROCE % Related Terms


Evonik Industries AG ROCE % Historical Data

* Premium members only.

The historical data trend for Evonik Industries AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evonik Industries AG ROCE % Chart

Evonik Industries AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.45 5.55 -0.64 4.01 4.46

Evonik Industries AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.21 6.56 -0.56 2.47 6.30
EVKIF
61GF Score
Evonik Industries AG EVKIF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evonik Industries AG ROCE % Calculation

Evonik Industries AG's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=749.415/( ( (20680.628 - 4250.262) + (21055.035 - 3896.956) )/ 2 )
=749.415/( (16430.366+17158.079)/ 2 )
=749.415/16794.2225
=4.46 %

Evonik Industries AG's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=1082.08/( ( (21055.035 - 3896.956) + (21337.572 - 4160.694) )/ 2 )
=1082.08/( ( 17158.079 + 17176.878 )/ 2 )
=1082.08/17167.4785
=6.30 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 6.30% mean?
Evonik Industries AG (EVKIF) has a ROCE % of 6.30% as of Mar. 2026.
Is Evonik Industries AG's ROCE % too high?
Evonik Industries AG's current ROCE % is 6.30%. The Chemicals industry median ROCE % is 6.45. Evonik Industries AG's value of 6.30% is 2.2% below this industry median. Overall, Evonik Industries AG has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Evonik Industries AG's ROCE % compare to LIN and SHW?
Evonik Industries AG's ROCE % of 6.30% can be compared against companies in the Chemicals industry. The industry median ROCE % is 6.45. Evonik Industries AG's value of 6.30% is 2.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Chemicals company?
The median ROCE % among Chemicals companies is 6.45, based on 1,594 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evonik Industries AG's current ROCE % of 6.30% is 2.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median ROCE % is 6.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evonik Industries AG's current ROCE % is 6.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evonik Industries AG stock overvalued right now?
Based on GuruFocus' analysis, Evonik Industries AG (EVKIF) is currently considered Fairly Valued. The stock's GF Value™ is $17.29, compared to a current price of $17.25 — trading 0.2% below its estimated fair value. The current ROCE % is 6.30% and 2.2% below the Chemicals industry median of 6.45. Evonik Industries AG's overall GF Score™ is 61/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Evonik Industries AG (EVKIF), the current ROCE % is 6.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evonik Industries AG (EVKIF) Overvalued in 2026?

Based on GuruFocus' analysis, Evonik Industries AG stock appears to be undervalued. The current stock price of $17.25 is trading 0.2% below its estimated GF Value™ of $17.29. GuruFocus considers Evonik Industries AG to be Fairly Valued.

Key valuation signals for EVKIF:

  • ROCE %: 6.30%
  • GF Value™: $17.29 vs. price of $17.25 (0.2% below fair value)
  • GF Score™: 61/100 with 8 warning signs
  • Industry Position: 2.2% below the Chemicals median

No single metric tells the full story. See the EVKIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Evonik Industries AG Business Description

Address Rellinghauser Strasse 1-11, Essen, NW, DEU, 45128
Evonik Industries AG is a chemicals company that develops and manufactures specialty chemicals and solutions for a wide range of industries. Its products include high-performance polymers, hydrogen peroxide, silicas, additives for coatings and adhesives, and amino acids for animal nutrition. It operates through three segments: Advanced Technologies, which focuses on technology-driven businesses such as high-performance polymers, silicas, and hydrogen peroxide; Custom Solutions, which develops additives, catalysts, and ingredients for personal care and pharmaceutical applications; and Infrastructure, which provides site-related infrastructure services and includes the Oxeno C4 chemicals business. It generates sales across Europe, Middle East & Africa, the Americas, and Asia-Pacific.
61GF Score

Get the complete analysis for EVKIF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.25
Price
$17.29
GF Value